.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Fuji
Novartis
Citi
US Department of Justice
Teva
Express Scripts
Dow
Accenture
Medtronic

Generated: September 23, 2017

DrugPatentWatch Database Preview

Desvenlafaxine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for desvenlafaxine and what is the scope of desvenlafaxine freedom to operate?

Desvenlafaxine
is the generic ingredient in four branded drugs marketed by Alembic Pharms Ltd, Osmotica Pharm Corp, Teva Pharms Usa, Sun Pharma Global, Sandoz Inc, Actavis Labs Fl, Lupin Ltd, West-ward Pharms Int, Wyeth Pharms Inc, and Mylan Pharms Inc, and is included in twelve NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for desvenlafaxine. Three suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: desvenlafaxine

Tradenames:4
Patents:2
Applicants:10
NDAs:12
Drug Master File Entries: see list16
Suppliers / Packagers: see list3
Bulk Api Vendors: see list58
Clinical Trials: see list60
Patent Applications: see list1,212
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:desvenlafaxine at DailyMed

Tentative approvals for DESVENLAFAXINE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe50MGTABLET, EXTENDED RELEASE;ORAL
► Subscribe► Subscribe100MGTABLET, EXTENDED RELEASE;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
PRISTIQ
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL021992-003Aug 20, 2014ABRXYesNo► Subscribe► SubscribeY ► Subscribe
West-ward Pharms Int
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL204083-001Feb 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alembic Pharms Ltd
DESVENLAFAXINE
desvenlafaxine
TABLET, EXTENDED RELEASE;ORAL204150-002Mar 4, 2013BCRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL204095-001Jun 29, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
PRISTIQ
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL021992-001Feb 29, 2008ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Lupin Ltd
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL204172-002Jun 29, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
DESVENLAFAXINE
desvenlafaxine fumarate
TABLET, EXTENDED RELEASE;ORAL205208-001Oct 11, 2013DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
DESVENLAFAXINE
desvenlafaxine fumarate
TABLET, EXTENDED RELEASE;ORAL205208-002Oct 11, 2013DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL204065-002Jul 29, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
DESVENLAFAXINE
desvenlafaxine fumarate
TABLET, EXTENDED RELEASE;ORAL205583-002Jan 28, 2014RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Fuji
Federal Trade Commission
QuintilesIMS
Farmers Insurance
Covington
Medtronic
Boehringer Ingelheim
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot